Julien Cachat
Clinical Scientist at Priothera SAS- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
French Native or bilingual proficiency
-
English Professional working proficiency
Topline Score
Bio
Credentials
-
Design and Interpretation of Clinical Trials
Coursera Course CertificatesMar, 2018- Oct, 2024 -
Cleaning data in R
DataCampFeb, 2018- Oct, 2024 -
Data Science: R Basics
HarvardxFeb, 2018- Oct, 2024 -
Master in science in Oncology
- -
Medical degree
- -
PhD in biochemistry
-
Experience
-
Priothera SAS
-
France
-
Biotechnology Research
-
1 - 100 Employee
-
Clinical Scientist
-
Sep 2021 - Present
-
-
-
Stalicla
-
Switzerland
-
Biotechnology Research
-
1 - 100 Employee
-
Research and Clinical Operations Manager
-
Sep 2020 - Aug 2021
- Scientific Lead for 3 biomarker studies- Support regulatory submissions (e.g. IRB, IND)- Review and provide medical and scientific input on IB, study protocol, DSMB charter, ICF and CRFs- Draft lab manuals
-
-
Research and Clinical Operations Associate
-
Jan 2019 - Sep 2020
- Oversee Phase1-enabling safety/tox preclinical studies- Support regulatory submissions (e.g. IRB, IND)- Main contact for lab vendors- Provide support to manage regulatory CRO, CMO and academic partners
-
-
Assistant Project Manager
-
Aug 2018 - Jan 2019
- Provide support to manage regulatory CRO, CMO and academic partners- Data analysis- Literature review
-
-
-
Hôpitaux Universitaires de Genève
-
Switzerland
-
Medical Practices
-
1 - 100 Employee
-
Médecin interne, service de pathologie
-
Nov 2015 - Oct 2016
-
-
-
Université de Genève
-
Switzerland
-
Higher Education
-
1 - 100 Employee
-
Research assistant
-
Dec 2010 - Oct 2015
My thesis project consist in studying the role of the NADPH oxidase 2 (NOX2) during the crosstalk between innate and adaptive immunity.An inherited mutation of NOX2 gene causes a disease called chronic granulomatous disease (CGD). CGD patient suffers from recurrent infection and is also more susceptible to developp auto-immune disease. During my project I aim to characterize the consequence of NOX2 deficiency on T and B lymphocyte response.Karl-Heinz Krause's laboratory has a long experience in the study of the NOX family. In this context, one of my function is to develop a new side of research and to develop tools to study immune response in vivo and ex vivo in this laboratory.
-
-
Education
-
Swiss commission for technology and innovation (CTI)
CTI Entrepreneurship Training: business concept, business, financing -
Université de Genève
PhD, Biochemistry -
University of Nottingham
Master of Science (MSc), Oncology and Cancer Biology -
University of Lausanne (Switzerland)
medical degree, Medicine